Kidney Health

Of 8,059 serum-creatinine readings Loop ran on urban working professionals in the latest 12-month window, just 1.0% sit above the 1.3 mg/dL threshold that flags impaired filtration. Blood urea is cleaner still — 0.2% elevated across 7,197 reports. Against a backdrop where chronic kidney disease affects an estimated 10–17% of the Indian adult population, with diabetes and hypertension as the dominant drivers (Singh et al., BMC Nephrology, 2013), the working-age kidney is, for now, holding.

Two of these three markers describe a kidney doing its job. The third does not describe the kidney at all. It describes the chemistry arriving at the kidney's door. That gap — intact filtration, elevated metabolic load — is the whole story on this page, and it is worth being precise about why.

Creatinine is normal because the damage hasn't reached the kidney yet#

The creatinine distribution is overwhelmingly clustered in the normal band. Of the small share that deviates, most are only mildly elevated.

The honest reading is not that this workforce has healthy kidneys. It is that this workforce is young enough that kidney damage, which accrues over ten to twenty years of metabolic and vascular insult, has not yet surfaced in the filtration markers. Creatinine elevation in this dataset is almost entirely an age signal: 0.3% in the 20s, rising to 4.1% past 60.

The gradient is steep in relative terms — a fourteen-fold increase from the 20s to the 60s — but the absolute numbers stay small. Even in the oldest band, fewer than one in twenty shows impaired filtration. The dependent layer, which skews older, sits at 1.7% against the employee layer's 0.6%, consistent with the age difference rather than any separate access gap.

The sex split on creatinine is worth a moment, because it explains why the threshold is the way it is. Men run higher than women at every age, and the elevation rate is roughly double in the older bands.

The male average creatinine is 0.91 mg/dL against the female 0.68 — a 34% difference that is biology, not pathology. Men carry more skeletal muscle, muscle generates creatinine, and so the same 1.3 mg/dL ceiling sits closer to the male baseline than the female one. This is why clinical creatinine thresholds and the eGFR equations derived from them are sex-adjusted: a creatinine of 1.2 mg/dL is unremarkable in a muscular man and a warning in a slight woman. Reading creatinine without sex correction would systematically over-flag men and under-flag women.

The real kidney signal is hyperuricemia, and it is a men's signal#

One marker on this page does not follow the reassuring pattern. 16.8% of professionals are hyperuricemic — uric acid above 6 mg/dL in women, above 7 in men. And unlike creatinine, this is not a quiet age signal sitting in the oldest band. It is concentrated, it is large, and it splits hard by sex.

More than one in five men tested are above the hyperuricemia threshold, against one in ten women — a 2.1× gap that is wider than the gender gap on almost any other biomarker in this report. The male average uric acid of 6.07 mg/dL sits close enough to the 7.0 male threshold that a meaningful share of men are one dietary or metabolic shift away from crossing it.

At the population level — both sexes pooled — hyperuricemia does not follow the clean age ramp that creatinine does. It is U-shaped, high in the 20s and 30s, dipping through middle age, and rising again past 60.

The dip is misleading on its own. It is the artefact of two opposing sex curves cancelling each other through middle age — the male rate falling while the female rate rises. The pooled line is the kind of average that describes no actual person, which is why the gender split below is the read that matters.

The sex pattern flips with age — men peak in their 30s, women after menopause#

The population-average gender gap conceals a cleaner story underneath. When hyperuricemia is cut by sex and age together, the two curves move in opposite directions.

Men are at their worst young. One in four men in their 20s and 30s is hyperuricemic, and the rate then falls through middle age. Women start low — one in fifteen in their 20s — and climb steadily, overtaking men in the 50s and reaching 27.2% past 60. The curves cross somewhere between the 40s and the 50s, and the timing lines up with menopause and the loss of oestrogen's uricosuric effect — the same oestrogen-withdrawal flip the Gender Divide page traces across bone, lipids, and uric acid at once.

The male peak in early career is the more striking half. It runs against the usual reading of biomarkers as conditions that accumulate with age. Hyperuricemia in this workforce is heaviest in the men who are youngest — the same band where diet, alcohol, and weight gain tend to be least monitored and most assumed away.

Pune men carry three times the hyperuricemia of Pune women#

The city cut deepens the male story. Across all five metros the male rate runs well ahead of the female rate, but the gap is widest in Pune, where men are more than three times as likely as women to be hyperuricemic.

Bengaluru men post the single highest city-level rate at 25.7%, and Delhi NCR is close behind at 24.8%. Mumbai is the one metro where the sexes converge — men at 18.3%, women at 12.7% — driven mostly by Mumbai women running higher than their counterparts elsewhere, consistent with the broader pattern of Mumbai being unusually hostile to women's biomarkers across this dataset. The intercity spread on the male side, from Mumbai's 18.3% to Bengaluru's 25.7%, is narrower than the within-city sex gap. Sex is the stronger axis here than geography.

High uric acid travels with high blood sugar#

Uric acid earns its place on a kidney page not as a filtration marker but as a member of the metabolic cluster that ends in kidney disease. The dataset shows the cluster directly. Among professionals who are hyperuricemic, 44.2% also show glucose dysfunction (HbA1c ≥5.7%), against 36.2% of those with normal uric acid.

The eight-point gap is an audience-level co-occurrence, not a member-level causal chain — the biomarker file is not linked to a longitudinal record, so we cannot say uric acid caused the glucose dysfunction or the reverse. The mechanism runs both ways in the literature: insulin resistance reduces renal uric-acid clearance, and uric acid in turn impairs the endothelial function that supports insulin signalling. What the data establishes is association, and the association is strong enough that a high uric-acid result should prompt a glucose check, and a glucose result should prompt attention to uric acid.

What the normal creatinine is borrowing against#

The reassuring kidney numbers are best read alongside the glucose page, where 38.7% of the same broad audience shows abnormal glucose metabolism and 13.3% sits in the diabetic range. Diabetic nephropathy — kidney damage from diabetes — typically develops ten to twenty years after diabetes onset. A workforce that is metabolically loaded in its 30s but filtering normally is not a workforce without kidney risk. It is a workforce whose kidney risk has not yet matured into the marker that measures it.

This is the lag that makes kidney prevention easy to defer and expensive to ignore. The window between metabolic insult and filtration failure is long, silent, and — critically — modifiable. Glucose control, blood-pressure control, and uric-acid management during that window are what determine whether the diabetic 34-year-old reaches 55 with a working kidney or a failing one. The 1.0% creatinine elevation today is not a clean bill of health. It is a deadline that hasn't arrived.

A second read of the same point: the blood-urea figure is the cleanest marker on the page at 0.2% elevated, and urea elevation is itself a late and non-specific signal, sensitive to dehydration and protein intake as much as to filtration. The fact that both filtration markers are quiet while the metabolic markers are loud is the entire diagnostic shape of early kidney risk. Nothing on the filtration side is wrong yet. Everything that predicts it going wrong is already in motion.

The kidney page is the rare one in this report that opens with good news that is actually good: filtration in the urban working-age population is broadly intact, and creatinine elevation, where it appears, is small and age-bound. The substance sits one step before the kidney. Hyperuricemia at 16.8%, heavily male, peaking in the 30s, and co-travelling with glucose dysfunction, is the marker on this page that predicts the kidney disease the creatinine numbers haven't yet caught. The filtration is fine because the workforce is young. The metabolic chemistry that erodes filtration is already moving.